Saskia Carstensen Selected Research

signal peptide receptor

1/2022	A targetable 'rogue' neutrophil-subset, [CD11b+DEspR+] immunotype, is associated with severity and mortality in acute respiratory distress syndrome (ARDS) and COVID-19-ARDS.
9/2021	Increased Neutrophil-Subset Associated With Severity/Mortality In ARDS And COVID19-ARDS Expresses The Dual Endothelin-1/VEGFsignal-Peptide Receptor (DEspR): An Actionable Therapeutic Target.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Saskia Carstensen Research Topics

Disease

2	Neoplasms (Cancer) 01/2022 - 09/2021
2	Inflammation (Inflammations) 01/2022 - 10/2021
1	Asthma (Bronchial Asthma) 10/2021
1	COVID-19 09/2021

Drug/Important Bio-Agent (IBA)

2	signal peptide receptorIBA 01/2022 - 09/2021
2	Endothelin-1 (Endothelin 1)IBA 01/2022 - 09/2021
1	CytokinesIBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	prostaglandin D2 receptorIBA 10/2021
1	Prostaglandin D2IBA 10/2021
1	EndotoxinsIBA 10/2021
1	LigandsIBA 09/2021